bit.bio Adds Two New Human Cell Products to Address the Translation Gap and Accelerate Research and Drug Discovery for Neurodegenerative Disease
● Cell coding company bit.bio announces an expansion to its product portfolio to accelerate research into neurodegenerative diseases. ● Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) disease model offer a scalable and reproducible in vitro system to model neurodegenerative disease. ● Early access now available to microglial cells, which can provide the basis for … [Read more…]
